PATENT CLAIM ANALYSIS

Application Number: 15892247
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["530", "387100"]

Abstract:
The present invention relates to methods and compositions for use in inducing tumor-specific antibody mediated complement-dependent cytotoxic response in an animal having a tumor comprising administering to said animal a composition comprising a replication competent oncolytic virus wherein administration of the composition induces in the animal production of antibodies that mediate a CDC response specific to said tumor.

Claim (Index 2):
The method of  claim 1 , further comprising the step of confirming the presence of CDC response-producing antibodies in said serum after the replication competent oncolytic virus has been administered and before contacting said serum with said plurality of expression vectors.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.37209
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13535291', '14656397', '14876195', '14273476', '11470951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6179494421027677
- 35 USC 102 Novelty (BERT): 0.5701428305795607
- Combined Prediction Score: 0.613168780950447
- Mean Citation Score: 422.3317819999999
- Max Citation Score: 474.94214000000005
- Similarity Product: 358.84271650245665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test